technology development
Mylab, Hemex Health Partner to Develop POC Dx Tests
The companies will use fluorescence immunoassays and electrophoresis-based diagnostic solutions and will jointly introduce tests in the US, Europe, and Asia.
CareDx, IDbyDNA Partner to Develop Infectious Disease Dx for Transplant Patients
The test will identify more than 100 pathogens, as well as drug resistance in viruses and bacteria.
Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test
The companies will combine the Binx io diagnostic platform with Sherlock Bio's CRISPR technology to create an easy-to-use rapid test for the point of care.
Avida Biomed Developing Hybridization-Based Methylation Sequencing Panels for Cancer Dx
The firm touts a new hybridization probe design, which it says will enable small, focused panels that reduce sequencing costs and assay time.
Mammoth Biosciences, GSK Developing CRISPR-Based SARS-CoV-2 Diagnostic for Home Testing
In a study published last month, Mammoth demonstrated the technology's sensitivity, specificity, and speed compared to PCR-based COVID-19 testing.